Leishmaniasis, Mucocutaneous - 11 Studies Found
Completed |
: Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Mucosal Leishmaniasis : Leishmaniasis, Mucocutaneous : 2005-05-20 : Biological: Leish-111f + MPL-SE vaccine |
Completed |
: Clinical Trial of Miltefosine to Treat Mucosal Leishmaniasis :
: 2011-06-20 :
|
Recruiting |
: Low Antimonial Dosage in American Mucosal Leishmaniasis :
|
Recruiting |
: Dedicated QT Study in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis : Mucocutaneous Leishmaniasis : 2015-04-22 : Drug: Miltefosine |
Recruiting |
: Spermiogram Assessment in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis : Mucocutaneous Leishmaniasis : 2015-04-22 : Drug: Miltefosine |
Completed |
: Miltefosine to Treat Mucocutaneous Leishmaniasis :
: 2010-01-12 : Drug: miltefosine 2.5 mg/kg/day for 28 days |
Available |
: Compassionate Use of Sodium Stibogluconate (Pentostam) for Cutaneous and Mucocutaneous New World Leishmaniasis :
: Drug: sodium stibogluconate (Pentostam) 20 mg/kg IV every day for 20 or 28 days |
Recruiting |
: The Association of Miltefosine and Pentoxifylline to Treat Mucosal Leishmaniasis: A Clinical Trial in Brazil : Leishmaniasis : 2015-08-19 :
|
Completed |
: Miltefosine for Mucosal Leishmaniasis : Leishmaniasis : 2006-09-07 : Drug: miltefosine 2.5 mg/kg/day for 28 days |
Completed |
: Miltefosine (Long Course) for Bolivian Mucosal Leishmaniasis : Leishmaniasis : 2006-09-07 : Drug: miltefosine: 2.5 mg/kg/day for 42 days |